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Introduction 
Mucociliary clearance provides an important 
protective function in the nose. A variety of topically 
and systemically administered drugs are used to 
treat nasal pathologies and there is evidence that 
these therapies may modify nasal mucociliary clear- 
ance (NMCC). This review describes the methods 
of assessing NMCC and the effects upon it of 
therapeutic agents. 
Overall, mucociliary clearance is dependent on an 
adequate quantity of mucus of appropriate viscosity 
and elasticity, and on adequately functioning cilia. 
The nasal mucus blanket consists of two layers. The 
outer mucus layer (gel phase) is relatively viscous and 
moves over the surface of the cilia, which are sur- 
rounded by a serous periciliary fluid layer (sol phase) 
(1). The ciliated cells have between 120 and 200 cilia 
that project from the luminal surface of the cell into 
the mucus. In the anterior part of the nose, there is a 
paucity of cilia and the mucus moves slowly at about 
l-2 mm h- ‘. In the posterior part of the nose, mucus 
moves more rapidly at 10 mm min- ‘. The beat of 
cilia is quick and forceful in a forward propulsive 
stroke that is followed by a slower recovery stroke, 
and beat frequency in man is about 13 Hz in vitro at 
37°C. Beating activity is coordinated so that it 
appears to move from one region to another adjacent 
posterior one in a metachronous fashion. Fine par- 
ticulate matter, including bacteria, that enters with 
inspired air is filtered by adherence to the mucus film. 
This occurs both by impaction and as the result of an 
electrostatic surface charge. Most particles, including 
microorganisms, trapped by this moving carpet of 
mucus in the nose are propelled towards the pharynx 
where they are swallowed (2). A defect in any part of 
this system such as occurs in primary or secondary 
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ciliary disorders or cystic fibrosis, predisposes the 
individual to infection of the nose and paranasal 
sinuses (3). 
Measurement of mucociliary clearance in viva 
Several techniques have been developed to measure 
nasal mucociliary clearance in vivo and these have the 
advantage of being suitable for assessment of pro- 
longed treatment effects. Wanner (4) concluded that 
mucociliary activity could be assessed by two basi- 
cally different methods. Soluble tracers such as sac- 
charin dissolve in the gel and sol phases of the mucus 
and so measure transport of both sol and gel layers. 
Marker particles placed on the mucosa measure 
transport of the outer mucus layer. In normal con- 
ditions, both layers probably move simultaneously in 
the direction of the beating cilia and this is supported 
by the correlation observed between particle and 
saccharin transport times (5). There is evidence 
however, that in some circumstances the periciliary 
fluid layer can be propelled more rapidly than the 
overlying mucus layer (5-7) so that movement of the 
two layers may be dissociated. 
SACCHARIN TEST 
The most widely used method for in vivo assess- 
ment of NMCC is the saccharin test (8,9). This is 
commonly performed by first asking the subject to 
blow the nose to remove any excess secretions. A 
saccharin particle is placed on the medial surface of 
the inferior turbinate of one nasal cavity, at least 
7 mm behind the anterior end to avoid the area of 
mucosa where cilia beat in an anterior direction. The 
time from particle placement until the subject reports 
the first sensation of a sweet taste is measured and 
expressed as a clearance time. As a screening test to 
detect abnormal mucociliary clearance, the saccharin 
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test is reproducible (10,l l), inexpensive, readily avail- 
able and simple to perform in large numbers of 
patients (10). It has been recommended that those 
patients with clearance times of greater than 60 min 
should be investigated further for abnormalities of 
either mucus or ciliary components of clearance (10). 
DYE METHOD 
Other methods have utilized a dye to give a visual 
representation of nasal clearance based on the time 
taken for the dye to appear in the nasopharynx 
following its application to the anterior nasal cavity. 
In a study using indigo carmine, clearance times were 
longer than those obtained using saccharin, but the 
measures were positively correlated (12). Other 
coloured substances used to evaluate nasal mucocili- 
ary transport have included charcoal powder (13) 
and edicol-orange (14). 
RADIOGRAPHIC METHOD 
Nasal mucus velocity has been estimated by the use 
of 1 mm discs of TefIon, rendered radiopaque by 
bismuth trioxide. Five to ten of these are placed on 
the superior surface of the inferior turbinate and a 
fluoroscopic image intensifier used to follow their 
motion (15). In some cases one or more discs does 
not move, as a consequence of variability in path- 
ways of nasal flow, indicating a shortcoming in 
methods of assessing mucus velocity which use only 
one particle. Employing this method, group mean 
nasal velocities in healthy subjects have been 
recorded in the range 6.8-10.8 mm min - ‘. Values of 
nasal mucus velocity do not necessarily correlate with 
saccharin clearance times. The lack of correlation 
may be attributable in part to the solubility of 
saccharin in both gel and sol layers of mucus which 
contrasts with the insoluble nature of the Teflon 
discs. This method has the disadvantage of exposure 
to X-rays and is of greater complexity than the 
saccharin test. 
RADIOISOTOPIC METHOD 
Radioisotopes have also been used and their pas- 
sage along the nasal cavity recorded by the use of a 
collimator and scintillation counter placed alongside 
the subject’s face. These techniques have employed 
droplets of radiolabelled solutions, for instance 
[9h”T~] phytate (16), or saline labelled with p9mTc] 
(7). Alternatively droplets of suspensions have been 
used, for instance micro- or macroaggregated human 
albumin labelled with 1311 ( 17), or albumin micro- 
spheres labelled with [99”Tc] (18). Dispersion and 
streaming of the droplet have been observed to make 
accurate determination of transit rate difficult (17). 
In some individuals the droplet was placed too 
far anterior and so failed to move away from the 
unciliated area. 
Subsequently, non-dispersible radiolabelled par- 
ticles were assessed. These included insoluble spheri- 
cal beads of an anion exchange resin labelled with 
[99mTc] pertechnetate (19). Although the use of an 
insoluble particle overcomes the problems of disper- 
sion and streaming, single particles have been 
observed to remain stationary (19). Furthermore, 
methods employing insoluble radiolabelled particles 
are regarded (7) as assessing movement of the outer 
mucus layer, in contrast to those methods which 
employ soluble tracers and measure transport of both 
sol and gel layers. Radioisotope techniques have the 
advantage of permitting visual record of the progress 
of the labelled agent and determination of transit rate 
in different parts of the nasal cavity, and it has been 
noted that transit rate tends to increase in the pos- 
terior portion of the nasal cavity (19). Furthermore, 
they are more likely to reflect mean clearance than 
the saccharin method which measures clearance time 
of the most rapidly moving particles. However, they 
need expensive equipment to perform and little 
assessment has been made of their reproducibility. 
Techniques for sampling human nasal epithelial cells 
Both human and animal studies have suggested 
that cilia play an important role in maintaining the 
functional integrity of the airways and that efficient 
mucus clearance is dependent on coordinated pat- 
terns of ciliary activity and the total numbers of cilia 
involved. Investigations of nasal ciliary activity in 
vitro have consequently focused on measurements of 
ciliary beat frequency (CBF) in nasal epithelial tissue 
obtained in one of several ways: 
NASAL BRUSHING 
Nasal brushing is a non-invasive technique, which 
is relatively simple to perform, and may be carried 
out either in the absence or presence of local anaes- 
thesia. It is suitable for use in young children and 
patient tolerance is good. Generally a nylon brush of 
about 2 mm diameter is used to harvest the nasal 
mucosa from (i) the lateral nasal wall (20), (ii) 
between the turbinate and the lateral wall of the nasal 
cavity (21), (iii) the nasal septum at the level of 
inferior turbinate (22) and (iv) the inferior nasal 
turbinate itself (23), for direct observation. Multiple 
samples can be obtained at one time and brushing 
can be repeated. Using this sampling technique it is 
also possible to obtain single ciliated cells and strips 
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of ciliated epithelium, which are suitable for ultra- 
structural studies (21). 
A major disadvantage of the technique is that the 
area being sampled is small and therefore may not 
be representative of the actual site where any patho- 
genic features are being expressed. Also since all 
samples contain cells which are beating at different 
frequencies, it is suggested that small groups of 
ciliated cells are not used and that only cells which 
are fixed in tissue are investigated for CBF counts 
(23). 
CURETTE AND FORCEPS BIOPSIES 
Both these techniques are relatively simple and can 
be easily executed by trained personnel. The proce- 
dures are carried out under local anaesthesia with 
minimal discomfort to the patient and allow sam- 
pling of the nasal mucosa under both natural and 
experimental situations. Both techniques have been 
widely used in obtaining human nasal epithelial cells 
(24,25) and it has been suggested that the number 
and the vitality of cells obtained is dependent on the 
sharpness of the curette and biopsy forceps and the 
site and force used for sampling. 
Ingels and colleagues (26) have compared the 
two sampling methods and concluded that forceps 
biopsies are preferable to curette obtained specimens, 
since the beating pattern and CBF in samples taken 
by biopsy forceps was more constant than in curette 
samples. These authors have also suggested that a 
‘continuous layer of ciliated cells’, in contact with 
basal membrane is desirable for measurements of 
CBF in vitro. 
NASAL SURGERY 
The major limitation of the techniques described 
above is the small quantity of specimens obtained. 
In contrast, nasal surgery, e.g. turbinectomy and 
polypectomy provide abundant material for both 
direct observation (27) and for culture of nasal 
epithelial cells which have also been used in 
investigations of nasal ciliary activity (28). 
Measurement of diary beat frequency in vitro 
Since the early 1930s (29), several attempts have 
been made to study ciliary motility. In both human 
and mammalian epithelium, the cilia beat at such 
high frequencies that direct observation allows only 
the registration of dramatic changes in the CBF, 
and therefore makes this form of investigation of 
limited value, except in the case of total arrest of 
ciliary motility (30). Although more recent investi- 
gations involving measurement of ciliary activity in 
vitro, have employed more sophisticated techniques, 
these too have had inherent problems. Additionally, 
due to variability in values of CBF in samples 
obtained by either brushing, curette or biopsy 
forceps, different investigators have set different 
criteria for the type of cells to study. For example 
Deitmer and colleagues (31) and Bernstein and 
colleagues (32) have suggested that the ciliary 
activity of only the most ‘actively beating cells’ 
should be investigated, since only these cells repre- 
sent the majority of ciliated cells in the epithelial 
tissue under investigation. Devalia and colleagues, 
on the other hand, have taken into consideration 
the variability in the ciliary activity in different 
areas of the airway tissue and measured the CBF in 
randomly chosen areas of cultured human bronchial 
and nasal epithelial cells (28). More recently, 
Rusznak and colleagues have demonstrated that the 
ciliary beat frequency of cultured human bronchial 
epithelial cells, in vitro, may be influenced by diur- 
nal rhythms (33). These authors suggest that in 
studies involving repeated measurements of ciliary 
activity in human airway tissue, over a period of 
several days, measurements of ciliary activity and 
associated parameters such as changes in intracellu- 
lar concentrations of CAMP and Ca2’ should be 
made at the same time each day. 
VISUAL METHOD 
Forrest and colleagues (34) employed a simple way 
of assessing ciliary motility. Nasal mucosa from the 
inferior turbinate was examined directly after biopsy, 
by phase contrast light microscopy, and the ciliary 
motility was assessed on a graded scale of @3; 0 
being absent, 3 being vigorous. Stafanger and col- 
leagues (25) have investigated, by direct visualization, 
the degree of irregularity in ciliary beat, graded from 
0 (complete synchrony) to 5 (complete asynchrony), 
and suggested that the pattern of ciliary beat is also 
of significance, since the synchrony in ciliary beat 
determines the effectiveness by which the airways 
remove particles entrapped in the mucus. Despite the 
simplicity and the relative low cost of the direct 
observation technique, this method has serious 
limitations with regard to accuracy, owing to the 
investigators’s subjectivity. 
AUDIO METHOD 
Bleeker and Hoeksema (35) have used an auditory 
clicking device and made measurements of ciliary 
beat by synchronizing the click with the visu- 
ally observed ciliary action. This method is highly 
subjective and prone to gross errors in its final 
assessment. 
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STROBOSCOPIC METHOD 
Essentially this method involves synchronization 
of a stroboscope to the ciliary beat frequency viewed 
under a microscope (36,37). The flickering frequency 
of a stroboscope lamp is adjusted to the Bickering of 
the light reflexes on the ciliated epithelium and at the 
point where the stroboscope frequency equals the 
ciliary frequency the cilia exhibit the least movement. 
This method produces a single frequency value for 
regions of a ciliary membrane but is unable to 
provide frequency time variations within individual 
cells or differences in frequencies between adjacent 
cells. Furthermore, although the principle of the 
method is simple, the device is difficult to use and 
inaccurate at very low values of CBF. Additionally, 
as the flicker of the epithelium may vary, large 
experimental errors may be introduced into the 
frequency determination (38,39). 
CINEMATOGRAPHIC (PHOTOGRAPHIC) METHOD 
This method was first introduced by Proetz who 
used motion picture camera to record ciliary motion 
(29). This involved the illumination of ciliated cells 
and recording of the reflected flickering light reflex on 
motion picture film by use of a high speed camera. 
Following development, the film was projected onto 
a screen at reduced speed and the frequency of ciliary 
beat visualized and counted directly off the screen 
(40). This technique was further developed by 
Dalhamn (41) and Sanderson and Sleigh (42) who, 
respectively, used cameras capable of recording 
at rates of 220 and 500 frames s- ‘, thus allowing 
the estimation of the beat frequency with greater 
accuracy. 
With the introduction of video techniques, the 
classical motion picture cameras have been replaced 
by sophisticated and easier-to-use video cameras 
(43), capable of high speed recording and slow 
motion and still picture replay, allowing the study of 
individual aspects of single beat sequence, including 
amplitude, beat direction and coordination (44). 
PHOTOELECTRIC METHOD 
Photoelectric technique, in its various forms, is the 
most widely used technique for measuring CBF (45- 
47). In principle the technique allows a photosensitive 
cell to detect light variations produced by the move- 
ment of cilia, utilizing either transmitted (40,48) or 
reflected light (35). These techniques require the use 
of a parallel light beam which illuminates the epi- 
thelial surface along the visual axis. The varying 
reflection of the light from the cilia causes voltage 
variations in a photoelectric measuring device 
(photosensitive cell) connected to a photomultiplier 
and an amplifier. The frequency of the voltage vari- 
ations, correspond to the rate of ciliary beat and 
is either counted electronically or recorded on an 
oscilloscope. Estimation of the CBF from the record- 
ings on the oscilloscope can be performed by either 
counting the ‘blips’ on the oscilloscope screen (‘hand 
counting technique’) (49) or by a microcomputer 
performing the fast Fourier transform (digital spec- 
trum analyser) which provides rapid and complete 
analysis of CBF (50). The mucus layer, the cell 
bathing medium and the irregularity of the reflecting 
cell surface, however, can contribute to the differ- 
ences in the reflected light, making it difficult to know 
the exact origin of the surface reflections (51). 
Teichtal and colleagues (52) have modified the 
transmitted light technique, by viewing the ciliated 
cells on a video display unit, and estimating the 
ciliary activity in the specimen by means of a hand 
held probe placed against the television screen in 
front of each region of beating cilia. This process 
allows representative groups of cilia to be investi- 
gated and according to the authors, CBF of only four 
to five cilia from one cell at a time can be detected. 
The various transmitted light techniques appear to 
give reproducible results, are convenient to use and 
require minimal subjective assessment. Overall, the 
potential disadvantages of these techniques are detec- 
tion of unrelated vibrations and the inability of some 
systems to detect light changes produced by a single 
cilium or even cilia from one cell. 
LASER LIGHT-SCATTERING SPECTROSCOPY METHOD 
The laser light-scattering spectroscopy technique 
employs a safe low power laser source to emit a fine 
laser beam, of approximately 15 pm diameter, 
directly onto the specimen and analyses the reflected 
laser light spectrum for fluctuations in the back- 
scattered light intensity resulting from the moving 
cilia. The fluctuations of the back-scattered light are 
detected by a photomultiplier tube and the spectral 
structure of the resulting photocurrents is assessed 
either by standard spectrum analysis or autocorre- 
lation techniques. The method is simple, accurate, 
and reproducible, due to both the precise frequency 
and coherency of the laser light. The major disadvan- 
tages of the technique are that it is expensive and as 
is the case for all techniques measuring reflected light, 
is subject to error due to light scattered as a result 
of the slightest vibration in the fluid bathing the 
specimen (53). 
Using this technique, Lee and Verdugo (54) have 
estimated that the activity of 200-300 cilia, corre- 
sponding to a surface area of l-2 ciliated cells, can be 
measured readily. 
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Fig. I Schematic diagram of the system measuring ciliary beat frequency, in vitro 
ANALOGUE CONTRAST ENHANCEMENT TECHNIQUE 
The analogue contrast enhancement technique 
takes into account several difficulties encountered by 
other techniques employed for the measurement of 
CBF, in vitro. Devalia and colleagues (285-57) have 
demonstrated that this is a highly reproducible and 
comparatively safe and simple technique, which can 
be readily performed by unskilled personnel with 
minimal training. The technique involves transfer of 
the microscopic image of the specimen onto a tele- 
vision monitor, via a video camera, followed by 
electronic ‘stretching’ of the video signal such that the 
contrast is dramatically increased to allow visualiz- 
ation of the specimen far beneath the resolution 
limits of the optical microscope. Television signals 
relating to differences in light intensity resulting 
from ciliary motion at any specific point on the 
monitor screen, as pre-determined by positioning an 
electronic mouse-operated cross-hair light sensing 
probe directly over ciliated cells, are analysed by 
an on-line micro-computer, incorporating a PCX 
Video Digitiser Card and specifically programmed 
for this application. The differences in light intensities 
are computed directly into units of Hertz and 
therefore are not subject to any further manual or 
mathematical transformations. 
The ciliary motion is measured in randomly chosen 
areas of the specimen, the positions of which can 
be noted accurately with a horizontal and vertical 
Vernier scale on the microscope stage such that it is 
possible to make further recordings of the ciliary 
motion in the same area, at different time points 
during the study period. The microscopic images of 
the ciliary motion are recorded by use of a video 
camera and a high resolution videorecorder, thus 
enabling an independent observer to analyse the CBF 
of the specimen in a blinded manner and at any time 
in the future, by playing back the recording (Fig. 1). 
The effect of drugs on human nasal mucociliary 
clearance 
A variety of topically administered drugs are used 
in the treatment of nasal disease, and the intranasal 
route may also be used to deliver to the systemic 
circulation compounds difficult to deliver by the 
oral route. These include pharmacologically active 
polypeptides and proteins which are currently being 
developed, such as hormones and vaccines. The con- 
sequences of inhibited mucociliary clearance suggest 
that constituents of preparations intended for nasal 
delivery should not adversely affect the mucociliary 
clearance system. 
Nasal preparations of corticosteroids are widely 
used in the treatment of nasal disorders, particularly 
allergies, and most studies of their short term admin- 
istration have shown little effect on NMCC in vivo. 
Thus, topical budesonide aerosol administered for 1 
week to healthy volunteers (58) had no effect on nasal 
mucociliary clearance as assessed by the saccharin- 
dye test, and a further study of topical budesonide 
administered for 1 week in healthy subjects simi- 
larly found no reduction in clearance when post- 
treatment values were compared with baseline (59). 
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Beclomethasone dipropionate aerosol administered 
for 1 week did not alter saccharin transit time, 
whereas flunisolide nasal pump spray delayed transit, 
but this was attributed to the vehicle for flunisolide 
(60). In contrast, longer term studies by Scadding 
and colleagues (61) have demonstrated that 1 year 
treatment of perennial rhinitics with fluticasone 
propionate aqueous nasal spray led to a significant 
increase in nasal mucociliary clearance as assessed by 
saccharin test. This increase in clearance rate may 
have been the consequence of a beneficial action on 
the underlying rhinitis. 
Although animal studies suggest an excitatory 
effect of histamine on ciliary activity (62), intranasal 
application of a suspension of the Hi anti-histamine 
levocabastine was found to have no effect on NMCC, 
in healthy humans assessed using the saccharin-dye 
test (63). Using the same method of assessment, 
chlorpheniramine administered orally was found to 
bring about more rapid NMCC as well as a reduction 
in expelled nasal secretions in healthy adults during 
rhinovirus infection (64). It was suggested that 
increased secretions as occurred during rhinovirus 
infection might impede normal mucociliary clearance 
and the effect of chlorpheniramine in reducing secre- 
tions might help preserve mucociliary clearance. 
Topically administered a-adrenergic drugs are 
frequently used as nasal decongestants. In healthy 
human volunteers phenylephrine had no effect on 
nasal mucociliary transit times measured by the sac- 
charin test, but increased CBF in samples of nasal 
cilia obtained 10 min after the topical application of 
1% phenylephrine (65). The increase in CBF was 
attributed to the a-adrenergic stimulant effect of 
phenylephrine, while the lack of change in mucocili- 
ary transit time was thought to be due to the concur- 
rent reduction in nasal mucus volume and increased 
mucus viscosity caused by the a-adrenergic stimulus. 
These findings are in agreement with a study in 
healthy humans in which topical treatment for 1 
week with the a-agonist nasal decongestant phenyl- 
propanolamine, did not alter nasal mucociliary clear- 
ance assessed by the saccharin dye test (66). In 
neither of these studies was reference made to poss- 
ible effects of preservatives in the nasal preparation. 
Van de Donk and colleagues (67) acknowledged the 
possible effect of such additives by demonstrating 
that nasal saccharin clearance was prolonged by a 
xylometazoline preparation containing domiphen 
bromide and other additives. However, the effect of 
these additives in isolation was not assessed. 
Most nasal drops and sprays are presented as 
multi-dose preparations and contain a preservative in 
their formulation to prevent the growth of micro- 
organisms which might contaminate the preparation 
during its repeated use. There are a number of 
efficient preservatives and at present the choice of 
preservative is largely determined by its compat- 
ibility with other formulation ingredients and the 
packaging of the preparation. 
A knowledge of the effect of preservatives on nasal 
mucociliary clearance in humans should allow the 
best choice of preservative for use in nasal prepar- 
ations but few studies have studied the effect of these 
on nasal clearance in man in vivo. Van de Donk and 
colleagues (67) demonstrated prolongation of nasal 
saccharin clearance in man following the topical 
application of chlorbutol but further studies are 
required to exclude possible in vivo effects of other 
additives used in nasal preparations. 
The effect of drugs on ciliary beat frequency of 
human nasal epithelial cells, in vitro 
A number of studies have examined the effect of 
nasal preparations, on ciliary activity in vitro and 
have focused on the effects on CBF since, in addition 
to the rheological properties of mucus, this is thought 
to be an important factor influencing mucociliary 
clearance (68). Over the past two decades numerous 
studies have investigated the effect of these drugs on 
CBF of airway epithelial cells from both animal 
(69-71) and human (55, 72) tissue and several have 
suggested that CBF is neither different in humans 
compared with animals (27,70), nor in human nasal 
compared with bronchial epithelial cells (28). Indeed, 
some of these studies have suggested that the effects 
of drugs observed in different in vitro systems are 
comparable. 
The effects, on CBF, of drugs not exhibiting anti- 
allergic properties are summarized in Table 1. 
Rutland and colleagues have investigated the effect of 
the commonly used local anaesthetic lignocaine, on 
the ciliary activity of nasal cells obtained by nasal 
brushing (45). They found that this agent does not 
inhibit CBF, in vitro, at doses which produce local 
nasal mucosal anaesthesia in vivo. Higher concen- 
trations of lignocaine, however, led to high dose 
inhibition of ciliary activity. 
Robson and colleagues (73) and Staskowski and 
colleagues (74) have studied the effect of the /I2 
agonists salbutamol and terbutaline, and demon- 
strated that these agents increased the CBF in nasal 
brushings and adenoid tissue, respectively, 1 h 
onwards. Studies by Robson and colleagues have 
further demonstrated that this effect could be blocked 
by use of the p2 antagonist propranolol. These find- 
ings are in accordance with those of Devalia and 
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co-workers, who studied the effects of salmeterol, 
salbutamol, terbutaline and propranolol (55,75), on 
CBF in bronchial epithelial cell cultures in vitro, and 
suggest that jIZ adrenergic agents may be of particular 
significance in enhancing mucociliary clearance, in 
vivo. These authors have also investigated the effect 
of methacholine on CBF in their model and demon- 
strated that this agent also enhances the CBF of 
bronchial epithelial cells, an effect that can be 
blocked by atropine (75). Studies by Van de Donk 
and colleagues (70), Robson and colleagues (73) and 
more recently Curtis and Carson (76) have shown 
that also sympathomimetics like naphazoline, 
xylometazoline and phenylephrine influence CBF of 
human nasal epithelial cells and may lead to a 
decrease in CBF at concentration as low as 0.1%. 
These findings suggest that adrenergic agonists may 
act directly on ciliated cells, and inhibit the frequency 
of ciliary beat. 
Arachidonic acid metabolites have been shown to 
play an important role in the pathogenesis of certain 
airway diseases and consequently have been investi- 
gated for their effects on ciliary motility. Using 
epithelial cells from nasal brushings Bonin and col- 
leagues (20) have recently reported that prostaglan- 
din E, (PGE,) and the prostacyclin analogue 
Iloprost, both exert cilia-stimulatory effects at con- 
centrations between lo- “-lO- 6 M. Whilst the effect 
of Iloprost can be successfully blocked by the 
cyclooxygenase inhibitor indomethacin (10 ~ 6 M) the 
effect of PGE, cannot. The authors conclude that 
arachidonic acid metabolites are important in the 
regulation of nasal ciliary activity. 
The mucolytic agent N-acetylcysteine at concen- 
trations which might occur locally in the nose, was 
found to reduce the CBF slightly in nasal cells 
obtained by curette technique (25). This effect was, 
however, fully reversible within 15 min. Similarly, 
antimicrobial and antiviral agents such as neomycin 
and ribavirin have also been shown to decrease the 
ciliary activity of nasal epithelial cells, in vitro, but 
this effect becomes manifest only after 5 h (22,23,58). 
Since most commercially available nasal drops 
contain absorption enhancers and preservatives in 
addition to the drug itself, the effect of these additives 
has also been investigated on CBF in human nasal 
preparations in vitro. Hermens and colleagues (77) 
have performed extensive studies of the effect of these 
additives in human adenoid tissue and demonstrated 
that a large number of the preservatives and absorp- 
tion enhancers decrease the ciliary beat frequency in 
this tissue. Taurocholate and glycolate at a concen- 
tration of 0.3% was shown to have a very mild effect 
on CBF as compared to the same concentration of 
deoxycholate, laureth-9 and sodium taurodihydro- 
fusidate which caused marked reduction or cessation 
of CBF after 10 min of administration. Preserv- 
atives such as chlorbutol (70), propylene glycol (78) 
and thiomersal (58) also showed non-reversible 
detrimental effects on CBF after 5-20 min. 
In recent years there has been a progressive 
increase in use of nasally administratable anti- 
inflammatory drugs with a concomitant increase in 
the number of studies investigating the effect of these 
preparations in vitro. The effect of anti-allergic drugs 
on the ciliary beat frequency of human nasal epithe- 
lial cells in vitro is shown in Table 2. Devalia and 
colleagues have investigated the effect of 10K5 M 
nedocromil sodium on the CBF of human nasal 
epithelial cells in culture and found no change in 
ciliary activity over a period of 24 h studied (57). In 
contrast, Stanley and colleagues (58) found that both 
betamethasone and betamethasone with neomycin 
drops were ciliotoxic to ciliated nasal epithelium. 
These authors concluded that this effect was likely to 
be caused by the preservative benzalkonium chloride 
and thiomersal. Further studies by the same group 
demonstrated that these preparations do not affect 
nasal clearance or ciliary beat frequency when admin- 
istered topically, in vivo. Stafanger (78) reported 
similar findings when investigating the effects of 
beclomethasone dipropionate (BDP). This author 
demonstrated a dose-related irreversible decrease in 
CBF after perfusion of nasal epithelium cells with 
either BDP or flunisolide, thereby suggesting that 
caution should be taken when the dose and/or length 
of the treatment is considered in vivo, although 
topical corticosteroid treatment has not generally 
been accompanied by impairment of NMCC in vivo 
(58-61). 
The importance of ciliary beat frequency and 
mucociliary clearance in disease states 
Most studies assessing nasal mucociliary clearance 
in disease states have employed the saccharin test. 
Using this method, significant prolongation of clear- 
ance times has been noted in non-allergic rhinitis, 
nasal polyposis (79), asthma (80), bronchiectasis (81), 
ciliary dyskinesia (lo), and in school children with 
positive skin test responses and bronchial hyper- 
responsiveness (11) as well as following infection with 
cold viruses (82). When clearance is abnormal, it is 
often not clear whether it is impairment of ciliary 
beating or abnormality of mucus which is respon- 
sible. In a study using the saccharin test in patients 
with perennial rhinitis or chronic infected rhino- 
sinusitis with or without concomitant asthma or 
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bronchiectasis, all patient groups had significantly 
longer clearance times than a group of healthy sub- 
jects (83). In vitro examination of cilia demonstrated 
that the abnormal clearance was not due to an 
intrinsic ciliary defect but probably to be the result of 
a combination of mucus and ciliary factors in vivo. In 
a recent study, Veale and colleagues have investi- 
gated the variability in CBF in nasal tissue obtained 
by brushing in normal subjects and in patients with 
bronchiectasis (84). These authors demonstrated that 
although the CBF of the fastest beating cilia was 
similar in both groups, the CBF of the slowest 
beating cilia was lower and showed greater within 
subject variation in the bronchiectatic patients (84). 
Prolongation of nasal saccharin clearance has also 
been demonstrated in cystic fibrosis and is accompa- 
nied by normal ciliary beat frequency in samples of 
nasal epithelium, suggesting the presence of an 
abnormality of mucus in vivo (85). 
Conclusion 
With increased use of nasally administered phar- 
maceutical preparations it has become necessary to 
test these agents for both effectiveness and any 
associated toxic or adverse reactions. Although there 
are many reports of the effects of different thera- 
peutic agents on human nasal mucociliary clearance, 
in vivo, and ciliary beat frequency, in vitro, it has not 
been possible to elucidate the precise mechanism/s 
underlying these effects. This is partly because of the 
lack of a direct correlation between the findings of 
the in vivo and in vitro studies. It is likely that this 
discrepancy is a consequence of the differences 
between the study systems employed. It is clear that 
factors such as temperature, humidity, pH, viscosity 
and ionic strength of the incubation medium, are 
critical for growth, maintenance and function of the 
cells in vitro, and consequently have to be controlled 
rigorously in all studies employing in vitro models. In 
contrast, the concentration and therefore the bio- 
availability of a therapeutic agent, in vivo, is likely to 
be influenced by the pharmacokinetic profile of the 
drug in the preparation, and as such will be affected 
by factors such as (i) dilution of the drug in nasal 
mucus, (ii) continual removal of the drug by muco- 
ciliary clearance, (iii) absorption and clearance of the 
drug into the bloodstream, and (iv) binding of free 
drug to proteins and other components of the nasal 
mucosa. On the basis of the evidence available, it is 
likely that the preservative agent/s in the nasally 
administered drug preparation will also be influenced 
similarly. However, due to the marked attenuating 
effect of the preservative agents observed on ciliary 
activity in vitro, there is a clear need for the effect of 
these agents to be investigated individually in vivo, 
before any firm conclusions can be drawn on the 
specific effect of any nasally administered therapeutic 
preparation on the mucociliary component. 
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